From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. HIV/AIDS Clinical Care>
  4. AIDS Watch

Guidelines for Preventing and Treating HIV-Related OIs

The National Institutes of Health, the CDC, and the HIV Medicine Association of the Infectious Diseases Society of America have published an update of their 2004 guidelines for the prevention and treatment of HIV-related opportunistic infections (OIs). These guidelines — which appear in the March 24, 2009, edition of MMWR — were released prepublication last summer and reviewed in the July 21, 2008, issue of Journal Watch AIDS Clinical Care. The only major change in the guidelines since their release last summer relates to the treatment of hepatitis B virus (HBV) coinfection. Consistent with HIV treatment guidelines from the U.S. Department of Health and Human Services, the OI treatment guidelines now recommend antiretroviral therapy (ART), regardless of CD4-cell count, for all coinfected patients who require HBV treatment; those who choose to defer ART should receive agents that are active against HBV only.

Published in Journal Watch HIV/AIDS Clinical Care March 30, 2009

Citation(s):

Centers for Disease Control and Prevention (CDC). Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep 2009 Mar 24; 58:1. (http://www.cdc.gov/mmwr/pdf/rr/rr58e324.pdf)

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.